Alembic logo

Alembic financials and balance sheet

NSE: ALEMBICLTDBSE: 506235RealtySmall Cap

Formerly Alembic Chemical Works Co.
Last close ₹86.73down ₹3.55 (3.93%)BSE ₹86.85

Share price at the NSE close on 23 Oct 2026. Previous close ₹90.28.

52-week range of traded prices to 23 Oct 2026
₹70.46Low, 30 Mar 2026₹117.72High, 3 Sep 2026
Market cap
₹2,227 Cr1,101st largest listed
P/E
6.9
P/B
0.9
Dividend yield
2.77%
ROE
13.4%
ROCE
3.0%
Debt to equity
0.00
Volume, NSE
6,29,66348.5% delivered

10 years at a glance

Consolidated: the company and its subsidiaries together. ₹ crore, years to March.Alembic annual reports

Revenue, net profit and borrowings, ₹ crore

  • Revenue
  • Net profit
  • Borrowings

Operating and net margin, per cent

  • Operating margin
  • Net margin

The years either side of a change of basis do not compare. From the year to Mar 2020, part of the business was demerged on 26 Aug 2019, and figures before the change include the part that left.

Results for the year to Mar 2026

Consolidated: the company and its subsidiaries together. ₹ crore.

From revenue to net profit

  1. Revenue240
  2. Materials and goods−16
  3. Employee costs−37
  4. Other expenses−96
  5. Operating profit90
  6. Depreciation−12
  7. Other income+73
  8. One-off items0.0
  9. Finance costs−2.3
  10. Profit before tax149
  11. Tax−23
  12. Joint ventures+191
  13. Net profit317

What the company owns

  • Plant, investments and other assets₹2,405 Cr
  • Current investments₹97 Cr
  • Inventory₹52 Cr
  • Receivables₹32 Cr
  • Cash and bank₹3 Cr

What pays for it: net worth and liabilities

  • Net worth₹2,445 Cr
  • Other liabilities₹110 Cr
  • Owed to suppliers₹24 Cr
  • Borrowings₹11 Cr

Alembic business segments, year to Mar 2026

A reportable segment is a line of business the company must report on its own. Consolidated, ₹ crore, as the company reports them.Alembic segment results by quarter

Revenue by segment

₹240 CrTotal
  • Real Estate Business₹193 Cr80.6% of total
  • Active Pharmaceutical Ingredients Business₹47 Cr19.4% of total

Profit by segment

  • Real Estate Business₹81.2 Cr93.5% of total
  • Active Pharmaceutical Ingredients Business₹5.6 Cr6.5% of total

Segment results by year

Consolidated, ₹ crore, years to March.

  • Real Estate Business

    Revenue, ₹ crore
    Profit, ₹ crore
  • Active Pharmaceutical Ingredients Business

    Revenue, ₹ crore
    Profit, ₹ crore
₹ croreMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue of all businesses128747478127157222240
Company revenue, as in its results128747478127157222240
Revenue61234546101126190193
Revenue growth–−62.6%97.1%2.1%119.3%24.8%50.8%2.0%
Profit222131237518881
Profit growth–−90.0%502.2%−11.4%218.2%38.7%71.8%−7.8%
Margin35.7%9.5%29.1%25.3%36.7%40.8%46.4%42.0%
Return on capital32.9%2.2%7.9%5.4%14.4%17.7%25.6%18.7%
Assets93134215272320367443516
Liabilities2735485564779981
Capital employed6699167217256290344434
Revenue–51–3226323247
Revenue––28–––––
Revenue67–––––––
Profit is before tax and finance costs, the way companies report their segments.

Profit and loss

Consolidated, ₹ crore, years to March.Alembic quarterly results

₹ croreMar 2017Mar 2018Mar 2019Filed 16 MayMar 2020Filed 25 MayMar 2021Filed 11 MayMar 2022Filed 6 MayMar 2023Filed 18 MayMar 2024Filed 14 MayMar 2025Filed 12 JunMar 2026Filed 19 May
Revenue from operations144125128747478127157222240
13811410771626487101128150
Materials and goods bought4248453191169916
Employee costs––2121232124232737
Other expenses––4118303257689296
Operating profit before depreciation711213111440579490
Operating margin4.7%8.9%16.4%4.4%15.1%17.8%31.7%36.1%42.2%37.7%
Materials, % of revenue––34.9%42.5%12.8%14.0%5.0%5.8%4.1%6.8%
Employee costs, % of revenue––16.8%28.1%30.7%27.5%18.9%14.6%12.3%15.6%
Other expenses, % of revenue––31.8%24.9%41.4%40.7%44.4%43.5%41.4%39.9%
Depreciation and amortisation543345781112
Operating profit after depreciation271807934498378
Other income31372993108964557573
Finance costs0000000122
Profit before one-off items and tax32444893179897103156149
One-off items−600000−11000
Profit before tax27444893179887103156149
−12403126101123
Share of profit of joint ventures and associates118121187236329136110176166191
145163230329343222191269311317
Other comprehensive income––16−17345107−214−60−34−88
Total comprehensive income––247312687329−23209276230
Net margin100.8%130.1%180.4%445.2%466.4%283.9%149.8%170.6%140.0%132.2%
Net margin without joint ventures and associates19.1%33.4%34.0%125.8%18.8%110.2%63.4%59.0%65.2%52.5%
Materials, employee costs and other expenses are shown for the years they add up to operating expenses; for the years to Mar 2017 and Mar 2018 they do not, so they are left blank.

Balance sheet

Consolidated, ₹ crore, at 31 March.

₹ croreMar 2019Filed 16 MayMar 2020Filed 25 MayMar 2021Filed 11 MayMar 2022Filed 6 MayMar 2023Filed 18 MayMar 2024Filed 14 MayMar 2025Filed 12 JunMar 2026Filed 19 May
1,2291,4182,2972,4972,0782,1862,3392,445
Share capital5151515151515151
Reserves1,1781,3672,2462,4452,0272,1342,2872,394
0000091411
504659688490110101
97536843535443
1,2881,4712,4092,6322,2052,3292,5032,590
1,1861,3082,3072,4892,0322,1912,2982,392
102163102143172137205197
Net debt−45−113−23−28−47−5−45−89
Borrowings are counted again inside the liabilities due within a year and after a year. No balance sheet is on record for the years to Mar 2017 and Mar 2018, so its lines and the ratios worked from it are blank there.

Cash flow

Consolidated, ₹ crore, years to March.

₹ croreMar 2021Filed 11 MayMar 2022Filed 6 MayMar 2023Filed 18 MayMar 2024Filed 14 MayMar 2025Filed 12 JunMar 2026Filed 19 May
−2−18392386120
0−94522102139
−19−2811−38−140
Receivables−5−1−84−10−2
Inventories−19−33−2−4−747
Payables53−214−3−4
Other working capital0323−5219−1
Tax paid−2−9−71−16−19
Capital spending7101738
Free cash flow−10−1939218082
−3519726−27−54
−15−6−46−48−58−68
Dividends paid15546566161
Shares bought back000000
Shares issued000000
Net change in cash−52−5001−1
Capital spending is part of cash from investing, and dividends paid, shares bought back and shares issued are part of cash from financing. Each is shown as an amount on a line of its own, and the section's other items are in its total only. No cash flow statement is on record for the years to Mar 2017, Mar 2018, Mar 2019 and Mar 2020.

Per share

Consolidated, ₹ per share, years to March.Alembic dividend history

₹ per shareMar 2017Mar 2018Mar 2019Filed 16 MayMar 2020Filed 25 MayMar 2021Filed 11 MayMar 2022Filed 6 MayMar 2023Filed 18 MayMar 2024Filed 14 MayMar 2025Filed 12 JunMar 2026Filed 19 May
Earnings per share₹5.44₹6.10₹8.93₹12.82₹13.35₹8.65₹7.43₹10.46₹12.10₹12.36
Diluted earnings per share₹5.44₹6.10₹8.93₹12.82–₹8.65₹7.43₹10.46₹12.10₹12.36
Dividend per share₹0.20₹0.20₹0.20₹0.60₹0.20₹1.80₹2.20₹2.40₹2.40₹2.40
Book value per share––₹47.88₹55.22₹89.45₹97.23₹80.93₹85.11₹91.07₹95.22
Dividend payout3.7%3.3%2.2%4.7%1.5%20.8%29.6%22.9%19.8%19.4%
Shareholder yield––––0.6%0.3%3.0%2.6%2.4%3.4%
Market cap at the year end (₹ crore)9791,4231,0789082,6441,8601,5162,1432,5301,821

Ratios

Consolidated, years to March.Alembic PE ratio and valuation

RatioMar 2017Mar 2018Mar 2019Filed 16 MayMar 2020Filed 25 MayMar 2021Filed 11 MayMar 2022Filed 6 MayMar 2023Filed 18 MayMar 2024Filed 14 MayMar 2025Filed 12 JunMar 2026Filed 19 May
Revenue growth14.5%−13.1%1.9%–−0.6%6.4%62.7%23.8%40.9%8.2%
Operating profit growth−19.2%65.1%89.0%–237.6%25.8%189.5%41.0%64.8%−3.5%
Net profit growth−37.9%12.1%41.4%–4.2%−35.2%−14.1%40.9%15.7%2.2%
Earnings per share growth–12.1%46.4%–4.1%−35.2%−14.2%40.9%15.7%2.1%
––18.7%24.9%18.5%9.3%8.3%12.6%13.7%13.3%
–––6.1 pts−6.4 pts−9.2 pts−0.9 pts4.3 pts1.1 pts−0.5 pts
From the net margin–––27.5 pts1.2 pts−7.2 pts−4.4 pts1.2 pts−2.3 pts−0.8 pts
From asset turnover–––−21.3 pts−7.6 pts−2.0 pts3.4 pts3.0 pts3.3 pts0.3 pts
From borrowing–––−0.1 pts0.0 pts0.1 pts0.0 pts0.1 pts0.1 pts0.0 pts
Return on capital employed––1.5%0.0%0.3%0.4%1.6%2.2%3.5%3.2%
Cash conversion––––−0.6%−8.0%20.4%8.4%27.8%37.8%
Interest cover10.343.185.00.219.723.372.244.233.634.3
Debt to equity––0.000.000.000.000.000.000.010.00
Receivable days––3944697167464949
Inventory days––2914112,1122,8875,1203,6973,9791,161
Payable days––2021516936401,0041,2381,132530
Cash conversion cycle, days––1273051,4872,3184,1832,5042,897680
Working capital days––19229822311881640
Asset turnover––0.100.050.040.030.050.070.090.09
Assets per rupee of net worth––1.051.041.041.051.061.061.071.06
Sales per rupee of plant––0.970.570.550.590.971.211.641.41
Capital spending to depreciation––––1.860.210.010.180.623.09
Plant being built, % of plant in use––0.0%2.4%4.4%0.1%0.1%0.8%0.0%0.9%
Revenue growth, operating profit growth, net profit growth and earnings per share growth are left blank for the year to Mar 2020: between the two periods the company demerged a business, so the two are on different bases and the change is not worked out. No balance sheet is on record for the years to Mar 2017 and Mar 2018, so its lines and the ratios worked from it are blank there.

Growth and returns over 3, 5 and 10 years

Consolidated: the company and its subsidiaries together. Each window ends with the year to Mar 2026.

Return on assets, latest year
12.5%
Cash from operations against operating profit
132.7%
Measure10 years5 years3 years
Revenue growth, yearly rate6.7%26.7%23.6%
Profit growth, yearly rate3.1%−1.5%18.5%
Return on equity, average–11.4%13.2%
Return on capital employed, average–2.2%3.0%
Operating margin, average21.5%33.1%38.7%
Net margin, average219.9%175.3%147.6%
Asset turnover, average–0.070.09
Cash conversion cycle, days, average–2,5162,027
Interest cover, average36.641.537.4
Debt to equity, average–0.000.00

Where the cash came from and went

Consolidated: the company and its subsidiaries together. ₹ crore, added up over each window, which ends with the year to Mar 2026.

₹ crore5 years3 yearsLatest year
Cash from operations250229120
Cash from investing−28−55−54
Cash from financing−226−174−68
Capital spending474638
Dividends paid23017961
Shares bought back000
Shares issued for cash000
Borrowings raised14140
Borrowings repaid444

Accounting checks

Consolidated, years to March. Published tests of whether reported profit is backed by cash and the balance sheet.

CheckMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Piotroski score, out of 9Published threshold 3 points out of 9––––335566
Altman Z-scorePublished threshold 1.1––25.6632.2424.7522.8320.7719.4418.5921.43
Beneish M-scorePublished threshold −1.78––––−2.16−2.24−2.09−2.42−2.01−2.33
Profit not backed by cash, % of assetsPublished threshold 10 per cent of average total assets––––19.588.775.989.7110.389.86
Cash from operations to profit, 3 yearsPublished threshold 0.7 times––––––0.030.060.190.26
Receivables growth less revenue growthOur threshold 0 percentage points–––8.6254.273.83−8.62−39.5010.77−1.71
Inventory growth less cost-of-goods growthOur threshold 0 percentage points–––29.06123.4342.9844.49−40.257.63−127.63
Other current assets growth less revenue growthOur threshold 5 per cent of revenue–––−2.026.77−2.923.36−0.982.17−1.19
Assets under construction, years of additionsOur threshold 2 years of additions–––1.120.830.040.030.170.000.03
Effective tax ratePublished threshold 17.16 per cent−3.195.418.700.1418.7811.927.129.567.0315.34
Tax charged less tax paid, % of profitOur threshold 10 percentage points–––––2.68−0.399.01−2.972.32
A threshold marked as ours has no published figure; it is the line we read the check against.

Credit ratings

An agency's view of the chance the company repays a borrowing on time, from AAA, the highest, down to D, in default.

DateAgencyBorrowing ratedRatingOutlookAmount, ₹ Cr
31 Aug 2026ICRA Limited (opens in a new tab)Fund-based-Cash credit[ICRA]AA-Review, Re-affirmStable15
31 Aug 2026ICRA Limited (opens in a new tab)Fund-based/Non-fund based-Others[ICRA]AA-Review, Re-affirmStable25.50
31 Aug 2026ICRA Limited (opens in a new tab)Fund-based/Non-fund based-Others[ICRA]AA- /[ICRA]A1+Review, Re-affirmStable10
The latest rating on each borrowing. The agency's name opens its reasoning for the rating.